Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Concurrent Diffuse Dural and Leptomeningeal Enhancements in Brain Magnetic Resonance Imaging Following a Mild COVID-19 Infection: A Novel Case Report and Review of Literature

Author(s): Rashed Bawand, Masoud Ghiasian* and Mustapha Samadyan

Volume 20, 2024

Published on: 12 May, 2023

Article ID: e280323215040 Pages: 6

DOI: 10.2174/1573405620666230328110847

Price: $65

Abstract

Introduction: During the COVID-19 pandemic, various complications have been reported in patients with this infection worldwide, including a wide range of neurological disorders. In this study, we have reported a novel neurological complication in a 46-years-old woman who was referred due to a headache following a mild COVID-19 infection. Also, we have had a quick review of previous reports of dural and leptomeningeal involvements in COVID-19 patients.

Case Report: The patient's headache was persistent, global, and compressive with radiation to the eyes. The severity of the headache was increased during the disease course and was exacerbated by walking, coughing, and sneezing but decreased with rest. The high severity of the headache disrupted the patient’s sleep. Neurological examinations were completely normal, and laboratory tests did not have abnormal findings except for an inflammatory pattern. Finally, in the brain MRI, a concurrent diffuse dural enhancement and leptomeningeal involvement were observed, which is a new finding in COVID-19 patients and has not been reported so far. The patient was hospitalized and treated with Methylprednisolone pulses. After completing the therapeutic course, she was discharged from the hospital in good condition and with an improved headache. A repeated brain MRI was requested 2 months after discharge, which was completely normal and showed no evidence of dural and leptomeningeal involvements.

Conclusion: Inflammatory complications of the central nervous system caused by COVID-19 can occur in different forms and types, and clinicians should consider them.

[1]
Totura AL, Baric RS. SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2012; 2(3): 264-75.
[http://dx.doi.org/10.1016/j.coviro.2012.04.004]
[2]
Nassar MS, Bakhrebah MA, Meo SA, Alsuabeyl MS, Zaher WA. Middle east respiratory syndrome coronavirus (MERS-CoV) infection: Epidemiology, pathogenesis and clinical characteristics. Eur Rev Med Pharmacol Sci 2018; 22(15): 4956-61.
[PMID: 30070331]
[3]
Elrobaa IH, New KJ. COVID-19: Pulmonary and extra pulmonary manifestations. Front Public Health 2021; 9: 711616-6.
[http://dx.doi.org/10.3389/fpubh.2021.711616] [PMID: 34650947]
[4]
Bodro M, Compta Y, Sánchez-Valle R. Presentations and mechanisms of CNS disorders related to COVID-19. Neurol Neuroimmunol Neuroinflamm 2021; 8(1): e923.
[http://dx.doi.org/10.1212/NXI.0000000000000923] [PMID: 33310765]
[5]
Sancho-Saldaña A, Lambea-Gil Á, Liesa JLC, et al. Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection. Clin Med 2020; 20(4): e93-4.
[http://dx.doi.org/10.7861/clinmed.2020-0213] [PMID: 32518103]
[6]
Di Muzio B, Vadera S. Meningeal enhancement. Radiopaedia 2021.
[http://dx.doi.org/10.53347/rID-36908]
[7]
River Y, Schwartz A, Gomori JM, Soffer D, Siegal T. Clinical significance of diffuse dural enhancement detected by magnetic resonance imaging. J Neurosurg 1996; 85(5): 777-83.
[http://dx.doi.org/10.3171/jns.1996.85.5.0777] [PMID: 8893714]
[8]
Antony J, Hacking C, Jeffree RL. Pachymeningeal enhancement—a comprehensive review of literature. Neurosurg Rev 2015; 38(4): 649-59.
[http://dx.doi.org/10.1007/s10143-015-0646-y] [PMID: 26264063]
[9]
Tosaka M, Sato N, Fujimaki H, et al. Diffuse pachymeningeal hyperintensity and subdural effusion/hematoma detected by fluid-attenuated inversion recovery MR imaging in patients with spontaneous intracranial hypotension. AJNR Am J Neuroradiol 2008; 29(6): 1164-70.
[http://dx.doi.org/10.3174/ajnr.A1041] [PMID: 18417608]
[10]
Newman NJ, Jankovic J, Mazziotta JC, Pomeroy SL. Bradley’s neurology in clinical practice. Elsevier 2021.
[11]
Fadakar N, Ghaemmaghami S, Masoompour SM, et al. A first case of acute cerebellitis associated with coronavirus disease (COVID-19): A case report and literature review. Cerebellum 2020; 19(6): 911-4.
[http://dx.doi.org/10.1007/s12311-020-01177-9]
[12]
Freire-Álvarez E, Guillén L, Lambert K, et al. COVID-19-associated encephalitis successfully treated with combination therapy. Clin Infect Pract 2020; 7-8: 100053.
[http://dx.doi.org/10.1016/j.clinpr.2020.100053] [PMID: 33163956]
[13]
Cheng F, Tang K. A case of COVID-19 encephalitis with anti-gfap antibody-positive meningoencephalomyelitis. J Neurol Sci 2021; 429: 119908.
[http://dx.doi.org/10.1016/j.jns.2021.119908]
[14]
Khodamoradi Z, Hosseini SA, Gholampoor Saadi MH, Mehrabi Z, Sasani MR, Yaghoubi S. COVID-19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR. Eur J Neurol 2020; 27(12): 2668-9.
[http://dx.doi.org/10.1111/ene.14536] [PMID: 32926584]
[15]
Naz S, Hanif M, Haider MA, Ali MJ, Ahmed MU, Saleem S. Meningitis as an initial presentation of COVID-19: A case report. Front Public Health 2020; 8: 474.
[http://dx.doi.org/10.3389/fpubh.2020.00474] [PMID: 33072684]
[16]
Packwood R, Galletta G, Tennyson J. An unusual case report of COVID-19 presenting with meningitis symptoms and shingles. Clin Pract Cases Emerg Med 2020; 4(3): 316-20.
[http://dx.doi.org/10.5811/cpcem.2020.4.47557] [PMID: 32926675]
[17]
Rodrigo-Armenteros P, Uterga-Valiente JM, Zabala-Del-Arco J, et al. Optic neuropathy in a patient with COVID-19 infection. Acta Neurol Belg 2022; 122(3): 789-91.
[http://dx.doi.org/10.1007/s13760-021-01600-w] [PMID: 33528821]
[18]
Rodríguez de Antonio LA, González-Suárez I, Fernández-Barriuso I, Rabasa Pérez M. Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review. Mult Scler Relat Disord 2021; 49: 102783.
[http://dx.doi.org/10.1016/j.msard.2021.102783] [PMID: 33513521]
[19]
Turbin RE, Wawrzusin PJ, Sakla NM, et al. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit 2020; 39(4): 305-10.
[http://dx.doi.org/10.1080/01676830.2020.1768560] [PMID: 32419568]
[20]
Velonakis G, Karavasilis E, Filippiadis DK, Almyroudi MP, Korompoki E. Leptomeningeal enhancement due to COVID-19 on 3D-FLAIR and T1 Black-Blood MR imaging sequences. AJNR Am J Neuroradiol 2021; 42(7): E39-41.
[http://dx.doi.org/10.3174/ajnr.A7104] [PMID: 33985953]
[21]
Dixon L, Varley J, Gontsarova A, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm 2020; 7(5): e789.
[http://dx.doi.org/10.1212/NXI.0000000000000789] [PMID: 32457227]
[22]
Elkady A, Rabinstein AA. Acute necrotizing encephalopathy and myocarditis in a young patient with COVID-19. Neurol Neuroimmunol Neuroinflamm 2020; 7(5): e801.
[http://dx.doi.org/10.1212/NXI.0000000000000801]
[23]
Virhammar J, Kumlien E, Fällmar D, et al. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology 2020; 95(10): 445-9.
[http://dx.doi.org/10.1212/WNL.0000000000010250] [PMID: 32586897]
[24]
Novi G, Rossi T, Pedemonte E, et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 2020; 7(5): e797.
[http://dx.doi.org/10.1212/NXI.0000000000000797] [PMID: 32482781]
[25]
Djellaoui A, Seddik L, Cleret De Langavant L, Cattan S, Bachoud-Lévi AC, Hosseini H. Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection. J Neurol Neurosurg Psychiatry 2021; 92(1): 113-4.
[http://dx.doi.org/10.1136/jnnp-2020-323923] [PMID: 32718920]
[26]
Lersy F, Kremer S. Meningeal inflammation and cerebral vasculitis during acute COVID-19 with spontaneous regression. Intensive Care Med 2022; 48(2): 233-5.
[http://dx.doi.org/10.1007/s00134-021-06592-y] [PMID: 34913085]
[27]
Dogan L, Kaya D, Sarikaya T, et al. Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series. Brain Behav Immun 2020; 87: 155-8.
[http://dx.doi.org/10.1016/j.bbi.2020.05.022] [PMID: 32389697]
[28]
Palao M, Fernández-Díaz E, Gracia-Gil J, Romero-Sánchez CM, Díaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord 2020; 45: 102377.
[http://dx.doi.org/10.1016/j.msard.2020.102377] [PMID: 32698095]
[29]
Zhou S, Jones-Lopez EC, Soneji DJ, Azevedo CJ, Patel VR. Myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and myelitis in COVID-19. J Neuroophthalmol 2020; 40(3): 398-402.
[http://dx.doi.org/10.1097/WNO.0000000000001049] [PMID: 32604245]
[30]
Westhoff TH, Seibert FS, Bauer F, et al. Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient. Am J Transplant 2020; 20(11): 3216-20.
[http://dx.doi.org/10.1111/ajt.16223] [PMID: 32713123]
[31]
Rebeiz T, Lim-Hing K, Khazanehdari S, Rebeiz K. Behavioral changes without respiratory symptoms as a presenting sign of COVID-19 encephalitis. Cureus 2020; 12(9): e10469.
[http://dx.doi.org/10.7759/cureus.10469] [PMID: 33083172]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy